Evidence map›Paper›PMID 33614385›Full record

ReviewBeilstein journal of nanotechnology2021

A review on the biological effects of nanomaterials on silkworm (

Sandra Senyo Fometu, Guohua Wu, Lin Ma, Joan Shine Davids

Open access · diamondAbstract readReview
In one paragraph

Review in Beilstein journal of nanotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Synthesis and Processing of Nanomaterials Mediated by Living Organisms.Angewandte Chemie (International ed. in English) · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sandra Senyo Fometu *School of Biotechnology and Sericulture Research Institute, Jiangsu University of Science and Technology, Zhenjiang 212018, PR China.ORCID https://orcid.org/0000-0001-7229-558X
Guohua Wu *School of Biotechnology and Sericulture Research Institute, Jiangsu University of Science and Technology, Zhenjiang 212018, PR China.ORCID https://orcid.org/0000-0002-7886-8841
Lin MaSchool of Biotechnology and Sericulture Research Institute, Jiangsu University of Science and Technology, Zhenjiang 212018, PR China.
Joan Shine DavidsSchool of Biotechnology and Sericulture Research Institute, Jiangsu University of Science and Technology, Zhenjiang 212018, PR China.
Jiangsu University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of high-quality silkworm silk is of importance in sericulture in addition to the production of biomass, silk proteins, and animal feed. The distinctive properties of nanomaterials have the potential to improve the development of various sectors including medicine, cosmetics, and agriculture. The application of nanotechnology in sericulture not only improves the survival rate of the silkworm, promotes the growth and development of silkworm, but also improves the quality of silk fiber. Despite the positive contributions of nanomaterials, there are a few concerns regarding the safety of their application to the environment, in humans, and in experimental models. Some studies have shown that some nanomaterials exhibit toxicity to tissues and organs of the silkworm, while other nanomaterials exhibit therapeutic properties. This review summarizes some reports on the biological effects of nanomaterials on silkworm and how the application of nanomaterials improves sericulture.

Indexed as

biological effectsBombyx morinanomaterialsnanotechnologysericulture

Identifiers

PMID33614385
PMCPMC7884877
OpenAlexW3132617281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.